Tonix Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.

About TNXP

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. 

CEO
Seth Lederman
CEOSeth Lederman
Employees
142
Employees142
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
2007
Founded2007
Employees
142
Employees142

TNXP Key Statistics

Market cap
197.83M
Market cap197.83M
Price-Earnings ratio
-0.86
Price-Earnings ratio-0.86
Dividend yield
Dividend yield
Average volume
490.28K
Average volume490.28K
High today
$12.54
High today$12.54
Low today
$12.12
Low today$12.12
Open price
$12.27
Open price$12.27
Volume
217.56K
Volume217.56K
52 Week high
$69.97
52 Week high$69.97
52 Week low
$11.60
52 Week low$11.60

Stock Snapshot

As of today, Tonix Pharmaceuticals(TNXP) shares are valued at $12.41. The company's market cap stands at 197.83M, with a P/E ratio of -0.86.

As of 2026-06-01, Tonix Pharmaceuticals(TNXP) stock has fluctuated between $12.12 and $12.54. The current price stands at $12.41, placing the stock +2.4% above today's low and -1.0% off the high.

The Tonix Pharmaceuticals(TNXP)'s current trading volume is 217.56K, compared to an average daily volume of 490.28K.

During the past year, Tonix Pharmaceuticals(TNXP) stock moved between $11.60 at its lowest and $69.97 at its peak.

During the past year, Tonix Pharmaceuticals(TNXP) stock moved between $11.60 at its lowest and $69.97 at its peak.

TNXP News

TipRanks 4d
Tonix presents data from analysis of opioid use in adults with fibromyalgia

Tonix Pharmaceuticals (TNXP) presented data from a real-world claims analysis of opioid use in U.S. adults with fibromyalgia at the 2026 ASCP annual meeting, he...

Investing.com 4d
Tonix presents data on opioid use in fibromyalgia patients - Investing.com

...

Tonix presents data on opioid use in fibromyalgia patients - Investing.com
TipRanks 5d
Tonix Pharmaceuticals publishes TNX-1500 data in Journal of Clinical Immunology

Tonix Pharmaceuticals (TNXP) announced the publication of a paper, “First-in-Human, Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of TNX-1500, an...

More TNXP News

TipRanks 5d
Tonix Pharma Highlights Positive Phase 1 TNX-1500 Results

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

People also own

Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.